SHANGHAI, July 17, 2025 /PRNewswire/ — ZEISS Group has announced that Martin Fischer will assume the role of President and CEO of ZEISS Greater China, effective October 1, 2025. Fischer will report directly to Andreas Pecher, President and CEO of the ZEISS Group. He succeeds Maximilian Foerst, who joined the Executive Board of the ZEISS Group as President and CEO of Carl Zeiss Meditec AG on June 1, 2025. ZEISS Greater China oversees all business operations in mainland China, Hong Kong SAR, and Taiwan Region.
ZEISS remains firmly committed to Greater China. China is ZEISS’s largest market and a crucial cornerstone of our global presence. I’m delighted that Martin Fischer has accepted this important position, said Andreas Pecher. Martin is a seasoned leader with extensive knowledge of ZEISS and our customers. His familiarity will ensure a seamless transition as we continue to build on our Greater China strategy initiated under Maximilian Foerst’s leadership.
Martin Fischer joined ZEISS in 2006 and has held various leadership roles across different business segments, including Semiconductor Manufacturing Technology (SMT), Industrial Quality Solutions (IQS), and Research Microscopy Solutions (RMS). Since 2022, he has served as the Global Head of Sales, Service & Marketing for RMS. In this role, Fischer expanded the commercial organization to include marketing and customer experience. He also established and led several strategically crucial programs, enabling the RMS team to successfully market agnostic software and enter emerging growth markets in biotech, pharma, electronics, and semiconductors. Furthermore, Fischer has made significant contributions to regional growth initiatives in the US and APAC, as well as strategic programs for the ZEISS Group.
It’s a great honor to be appointed President and CEO of ZEISS Greater China. Maximilian successfully led all business segments in the region for 16 years, establishing a robust foundation for future growth, said Martin Fischer. I’m thrilled to lead the Greater China team, which comprises a strong and efficient management group and thousands of dedicated, passionate employees. The strategic development of ZEISS Greater China is a top priority for the Group, and I’m eager to drive further progress in innovation, localization, and across all business segments.
About ZEISS Group
ZEISS is a leading international technology enterprise specializing in optics and optoelectronics. For the fiscal year 2023/24, the ZEISS Group reported annual revenue of nearly 11 billion euros across its four segments: Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets (as of September 30, 2024). The company currently reinvests 15 percent of its revenue in science and R&D.
ZEISS develops, produces, and distributes cutting-edge solutions for industrial metrology and quality assurance, microscopy solutions for life sciences and materials research, and medical technology for diagnostics and treatment in ophthalmology and microsurgery. The ZEISS name is synonymous with world-leading lithography optics used by the chip industry to manufacture semiconductor components. There is global demand for innovative ZEISS products, including eyeglass lenses, camera lenses, and binoculars.
With a portfolio aligned with future growth areas such as digitalization, healthcare, and smart production, coupled with a strong brand, ZEISS is shaping the future of technology and advancing the world of optics and related fields. The company’s substantial, sustainable investments in research and development underpin ZEISS’s success and ongoing expansion in technology and market leadership.
Today, the ZEISS Group employs around 46,500 people globally across approximately 50 countries. The company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of Germany’s largest foundations dedicated to promoting science, is the sole owner of the holding company, Carl Zeiss AG.
For more information, visit www.zeiss.com
About ZEISS in Greater China
ZEISS’s presence in Greater China dates back to 1957. Today, ZEISS operates across all segments in the Greater China market, including Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets. Since 2021, China has become ZEISS’s largest single market worldwide and one of its most innovative and rapidly growing markets. In the fiscal year 2023/24, ZEISS in Greater China reported annual revenue of 15.1 billion RMB (approximately 11.3 million USD), a 12% increase from the previous year. With over 7,000 employees across more than 60 sites, including manufacturing facilities, sales and service offices, and R&D centers, ZEISS provides strong support to its regional customers and ensures international operations for all related businesses.
ZEISS Greater China’s headquarters is located in the Shanghai Pilot Free Trade Zone. It houses various operations, including the China Sales & Service headquarters, competence and training centers, a manufacturing facility for the ZEISS Industrial Metrology business group, and the Shanghai Innovation and R&D Center—ZEISS Group’s first corporate innovation and R&D center outside Germany. The regional headquarters and Innovation and R&D Center in Shanghai, along with the Suzhou R&D and Manufacturing Site and Guangzhou Knowledge Manufacturing Base, are creating an integrated industrial chain encompassing medical devices, high-end manufacturing, R&D equipment, and optical lenses. ZEISS is committed to supporting domestic R&D and collaborates closely with Chinese partners to ensure the high-quality and sustainable development of China’s cutting-edge industries.
For more information, visit www.zeiss.com.cn
Most Commented